| Island Foot Care Corp | |
|
1441 Kapiolani Blvd Ste 608, Honolulu, HI 96814-4403 | |
| (917) 613-1629 | |
| Not Available |
| Full Name | Island Foot Care Corp |
|---|---|
| Type | Facility |
| Speciality | Podiatrist - Foot & Ankle Surgery |
| Location | 1441 Kapiolani Blvd Ste 608, Honolulu, Hawaii |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477299410 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | (* (Not Available)) | Primary |
| Provider Name | Sadia Rizvi Shah |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1750518130 PECOS PAC ID: 5193974178 Enrollment ID: I20220902002245 |
News Archive
Ontario's doctors would like to congratulate NDP MPP Rosario Marchese, Trinity-Spadina, on the introduction of Consumer Protection Amendment Act, which would limit commercial advertising for unhealthy food or drink directed at children under the age or 13.
Neptune Technologies & Bioressources Inc. subsidiary Acasti Pharma Inc. reports preclinical results showing that its leading drug candidate CaPre, performed significantly better than the currently marketed drug, Lovaza, at managing impaired glucose tolerance (IGT) a serious pre-diabetic state associated with increased risk of diabetes and heart disease.
A new study reports a cell-based assay that involved the isolation and quantification of SARS-CoV-2 Mpro in human cells in the absence of other proteins.
Sagent Pharmaceuticals, Inc., a privately-held specialty pharmaceutical company, today announced U.S. FDA approval and launch of its topotecan hydrochloride for injection, a chemotherapy agent, in conjunction with the innovator's patent expiry. Sagent's topotecan is available in 4 mg single-dose latex-free vials.
Soo Young Lee and colleagues, at Ewha Womans University, Republic of Korea, have developed a cell-permeable inhibitor of the mouse protein RANK (which they termed RRI) that is likely to aid in the development of selective drugs to treat diseases that involve substantial bone loss, for example, osteoporosis, periodontitis, and arthritis.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Island Foot Care Corp 1578 Williamsbridge Rd Apt 3a, Bronx, NY 10461-6268 Ph: (917) 613-1629 | Island Foot Care Corp 1441 Kapiolani Blvd Ste 608, Honolulu, HI 96814-4403 Ph: (917) 613-1629 |
News Archive
Ontario's doctors would like to congratulate NDP MPP Rosario Marchese, Trinity-Spadina, on the introduction of Consumer Protection Amendment Act, which would limit commercial advertising for unhealthy food or drink directed at children under the age or 13.
Neptune Technologies & Bioressources Inc. subsidiary Acasti Pharma Inc. reports preclinical results showing that its leading drug candidate CaPre, performed significantly better than the currently marketed drug, Lovaza, at managing impaired glucose tolerance (IGT) a serious pre-diabetic state associated with increased risk of diabetes and heart disease.
A new study reports a cell-based assay that involved the isolation and quantification of SARS-CoV-2 Mpro in human cells in the absence of other proteins.
Sagent Pharmaceuticals, Inc., a privately-held specialty pharmaceutical company, today announced U.S. FDA approval and launch of its topotecan hydrochloride for injection, a chemotherapy agent, in conjunction with the innovator's patent expiry. Sagent's topotecan is available in 4 mg single-dose latex-free vials.
Soo Young Lee and colleagues, at Ewha Womans University, Republic of Korea, have developed a cell-permeable inhibitor of the mouse protein RANK (which they termed RRI) that is likely to aid in the development of selective drugs to treat diseases that involve substantial bone loss, for example, osteoporosis, periodontitis, and arthritis.
› Verified 8 days ago
Dr. Ken Sakuda, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 550 S Beretania St, 4081, Honolulu, HI 96813 Phone: 808-690-4727 Fax: 808-777-1016 | |
Ricky T Sukita, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 405 No. Kuakini St., Suite 1111, Honolulu, HI 96817 Phone: 808-596-0305 Fax: 808-521-1119 | |
Hawaii Foot Clinic, Llc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 50 S Beretania St, Suite C-111, Honolulu, HI 96813 Phone: 808-536-6584 | |
Kenson T Miyaki, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1029 Kapahulu Ave Ste 306b, Honolulu, HI 96816 Phone: 808-291-8298 | |
Suhair Afif Shahwan, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 1329 Lusitana St Ste 802, Honolulu, HI 96813 Phone: 509-438-5984 Fax: 509-438-5984 | |
Akamai Foot Doctor, Llc Podiatrist Medicare: Medicare Enrolled Practice Location: 932 Ward Ave, Suite 400, Honolulu, HI 96814 Phone: 808-942-3644 Fax: 808-955-7970 | |
Academy Foot Center Of Hawaii, Inc. Podiatrist Medicare: Medicare Enrolled Practice Location: 1329 Lusitana St Ste 801, Honolulu, HI 96813 Phone: 808-536-4335 Fax: 808-537-9195 |